Nachrichten zur Eli Lilly & Co. Aktie

With Zepbound Not Matching Expectations, Should Investors Give Up on Eli Lilly?

Over the past six months, Eli Lilly (NYSE: LLY) has underperformed broader equities. While thats not much of an issue…

Got $1,000? 2 Top Growth Stocks to Buy Right Now

Being a long-term investor isnt always easy, as youll inevitably encounter downturns as well as the thriving bull periods that…

3 Unstoppable Stocks You Can Buy and Hold for the Rest of Your Life

If you want stocks that you can buy and hold for not only years, but potentially the rest of your…

Jim Cramers week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir

CNBCs Jim Cramer on Friday walked investors through an earnings-heavy week.…

Eli Lilly CEO Hasn’t Bought Company Shares in Years. He Just Bought This Stock.

…

Wafaa Mamilli To Join Roche As Chief Digital Technology Officer

Wafaa Mamilli will join Roche as the companys new Chief Digital Technology Officer in February. This follows expansive roles she…

A mixed bag on Day 2 of the DeepSeek shock, plus Eli Lilly keeps its win streak alive

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.

Some people make it a New Years resolution to improve their finances by investing in stocks. Its a laudable goal,…

Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has…

Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It. @themotleyfool #stocks $LLY

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has…

Why Eli Lilly Stock Topped the Market Today

Eli Lilly (NYSE: LLY) stock was the picture of health on Friday. Shares of the massive American pharmaceutical company rose…

3 Richly Valued Stocks Ill Be Watching Like a Hawk in 2025

Investing in stocks with high valuations isnt necessarily a bad decision, but its something to be done deliberately and with…

Eli Lilly stock dips on Novo Nordisks rival drug data By Investing.com

Eli Lilly stock dips on Novo Nordisks rival drug data…

Stocks to Watch Friday: Novo Nordisk, Eli Lilly, Amex, Verizon

…

Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is the Stock in Trouble?

Eli Lilly (NYSE: LLY) has become a beast in healthcare. The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound, has…

The Zacks Analyst Blog Eli Lilly, Exxon Mobil, Costco and Flanigans

Eli Lilly, Exxon Mobil, Costco and Flanigans are included in this Analyst Blog.…

This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a…

Top Analyst Reports for Eli Lilly, Exxon Mobil & Costco

Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Exxon Mobil Corporation…

GLP-1 Drugs Cut Risk of Alzheimers, NVO & LLY Shares Rise

Shares of Novo Nordisk and Eli Lilly gain following study results that show GLP-1 drugs cut the risk of heart…

Eli Lilly: Market Overreacted

…

2 Corporate VC Models To Fuel Unicorn Success In Emerging Industries

This collaboration between Eli Lilly and a Top VC fund can redefine how Corporate VC (CVC) fuels innovation – not…

Should You Buy the Dip in Eli Lilly Stock Right Now?

Shares of pharmaceutical stock Eli Lilly are cratering after the company lowered its sales guidance for Q4.…

Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried?

In the first half of 2024, it seemed Eli Lilly (NYSE: LLY) could do no wrong. Unfortunately, the good times…

3 Unstoppable Stocks to Buy in 2025

You can look at the momentum for some stocks and have a feeling that its about to end. Others, though,…

Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity?

GLP-1 drugs have become all the rage for weight loss, with sales for drugs like Novo Nordisks Ozempic and …

Is Novo Nordisk Stock a Buy?

It hasnt been a great period for investors in Novo Nordisk (NYSE: NVO) despite its ongoing status as one of…

Could Donald Trump Make Eli Lilly Stock a No-Brainer Buy in 2025?

Eli Lilly (NYSE: LLY) began a roll in late 2020 that lasted almost four years. During that time, it became…

My 10 Top Stocks to Buy to Start the New Year Off Right

Investors scored big wins last year as the S&P 500, the Nasdaq, and the Dow Jones Industrial Average all climbed…

Eli Lilly: Big 2025 Ahead, But Execution Risks Exist

…

Eli Lilly: Whats Left To Like? A Lot, Says One Analyst.

The company cut its fourth-quarter guidance by 5%. But theres still a lot happening for Lilly.…

Has Eli Lilly Stock Peaked?

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of around $720…

JP Morgan 2025: Eli Lilly misses 2024 revenue estimate by $400m

…

Eli Lilly Stumbled But Weight-Loss Drugs Will Continue to Fuel Markets. Here’s Why and 5 Other Things to Know Today.

…

Eli Lilly and Company Aktie: Der Abwärtsdrift hält an

Der Pharmakonzern Eli Lilly and verzeichnete im vierten Quartal 2024 einen bemerkenswerten Umsatzanstieg von 45 Prozent auf 13,5 Milliarden US-Dollar.…

Eli Lilly: BofA says buy the dip after shares slide on Q4 miss By Investing.com

Eli Lilly: BofA says buy the dip after shares slide on Q4 miss…

The Zacks Analyst Blog Highlights J&J, Eli Lilly, GSK and Intra-Cellular

J&J, Eli Lilly, GSK and Intra-Cellular are included in this Analyst Blog.…

Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip

Eli Lilly slashes the revenue guidance for the fourth quarter and fiscal 2024 but offers a bullish outlook for 2025.…

Jim Cramer says he supports healthcare stocks for their long-term value

CNBCs Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and Regeneron.…

US stocks end mixed in choppy session as inflation data eyed

STORY: U.S. stocks ended mixed on Tuesday as investors gauged the latest inflation data and braced for quarterly earnings reports…

Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals

Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing health-related deals at the JPMorgan Health Care…

Stocks making the biggest moves midday: Eli Lilly, Applied Digital, Boeing and more

These are the stocks posting the largest moves in midday trading.…

Eli Lilly, Robinhood Lead Market Cap Stock Movers on Tuesday By Investing.com

Eli Lilly, Robinhood Lead Market Cap Stock Movers on Tuesday…

Eli Lilly shares tumble after cutting its sales outlook. What it means for investors

Shares plunged 7% after management said demand for its popular GLP-1 drugs did not meet expectations.…

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday

Bad news for Eli Lilly (NYSE: LLY) stock dragged down shares of rival companies in the market for GLP-1 diet…

Hims & Hers stock up as Eli Lilly GLP-1 sales miss (LLY:NYSE)

Eli Lilly (LLY) stock fell as its obesity therapy tirzepatide missed forecasts, amid focus on compounded weight loss drugmaker Hims…

Hims & Hers in focus as Eli Lilly obesity drug sales disappoint

Eli Lilly (NYSE:LLY) shares sold off on Tuesday after the Indiana-based pharma giants Q4 and 2024 preliminary sales results for…

Pharmakonzern Lilly erlöst 2024 weniger als gedacht

INDIANAPOLIS (dpa-AFX) - Der US-Pharmahersteller Lilly ist 2024 trotz eines Spurts vor Jahresende nicht so…

Pharmakonzern Lilly erhöht Dividende und kündigt weiteren Aktienrückkauf an

INDIANAPOLIS (dpa-AFX) - Der US-Pharmakonzern Lilly plant in den kommenden Jahren weiter Aktien im Milliardenvolumen…

AKTIE IM FOKUS: Abnehmmittel-Liebling Lilly strauchelt - Dreimonatstief

NEW YORK (dpa-AFX) - Die im März 2023 losgetretene Rally der Eli-Lilly-Aktien ist am Mittwoch…

ROUNDUP: Pharmakonzern Lilly senkt Ausblick - Abnehm-Medikamente unter Erwartung

INDIANAPOLIS (dpa-AFX) - Der US-Pharmahersteller Lilly hat im vergangenen Quartal nicht an das starke erste…